Benefits of Whole Genome Sequencing Part Two

This episode of the CBIA BizCast is the second of a two-part discussion on a key issue in Connecticut and across the country—whole genome sequencing. In this episode Paul Pescatello, CBIA senior counsel and executive director of the Connecticut Bioscience Growth Council speaks with Dr. Adam Matson and Dr. Louisa Kalsner from Connecticut Children’s. Dr. Matson is a neonatologist and lead researcher for Genomic Sequencing in the neonatal and pediatric population at the hospital. And Dr. Kalsner is the division head for Genetics. Doctors Mtson and Kalsner highlight the importance of whole genome sequencing in both research and clinical settings. They also discuss the technology’s future and its value to patients, caregivers, and families. Please click here for part one of our discussion on whole genome sequencing with Alexion Pharmaceuticals, Inc.’s Dr. Tom Defay: https://www.cbia.com/news/issues-policies/cbia-bizcast-whole-genome-sequencing